Stay updated on Tepotinib Phase II Clinical Trial
Sign up to get notified when there's something new on the Tepotinib Phase II Clinical Trial page.

Latest updates to the Tepotinib Phase II Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a small backend/frontend update to the study listing page.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedNew cross-registry identifiers from China and Japan registries were added (CTR20192576, jRCT2080223315, Japic CTI-163370) and the study revision updated to v3.6.4. Older identifiers and the previous revision (v3.6.3) were removed.SummaryDifference0.2%

- Check56 days agoChange DetectedRevision updated from v3.6.0 to v3.6.3 on the page. This indicates a version update, likely affecting underlying structure or metadata rather than visible content.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page now shows recruitment is no longer open to participants. New guidance sections—How to Read a Study Record, Common Questions, and How to Join a Study—have been added to help users navigate and understand the record.SummaryDifference0.2%

- Check77 days agoChange DetectedThe page footer now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a small build update without altering the study content.SummaryDifference0.0%

- Check98 days agoChange DetectedFooter revision updated from v3.5.3 to v3.5.4, indicating a minor site update. No changes to the study details or page structure are evident.SummaryDifference0.0%

Stay in the know with updates to Tepotinib Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tepotinib Phase II Clinical Trial page.